Dr. Anne-Marie Feyrer-MelkM.D.

Dr. Feyrer-Melk focuses on cardiovascular disease, arterial plaque, inflammation, high cholesterol, high triglycerides, hypertension, vascular disease, and the prevention of heart attack and stroke. She also addresses Type 2 diabetes prevention as part of her Bale Doneen Method practice. Her work extends to patients with hereditary cardiac risk who want proactive, individualized management.

Dr. Feyrer-Melk operates from the position that no amount of arterial disease is ever normal. She uses advanced non-invasive testing to detect silent plaque and identify cardiac risks that standard cholesterol and stress tests often overlook. Her individualized programs combine genetic, inflammatory, lipid, and saliva testing with Telomere and Cardiac DNA analysis. She also compounds custom low-dose sustained-release Niacin for patients who need it.

Yes. Dr. Feyrer-Melk practices the Bale Doneen Method and holds a Letter of Recognition for her dedication and proficiency in using it for the prevention of heart attacks, strokes, and Type 2 diabetes. She has also spoken at the Bale Doneen Conference, reflecting her deep engagement with this evidence-based methodology.

Dr. Feyrer-Melk has been in practice since 1997. She completed her training at Banner Samaritan Medical Center in Phoenix and earned her medical degree from the University of Wisconsin Medical School. That depth of experience informs her highly individualized approach to each patient's cardiac program.

Yes. Dr. Feyrer-Melk has incorporated genetic testing into her clinical practice for over ten years. She uses it alongside inflammatory, lipid, and saliva testing to build a detailed picture of each patient's cardiac risk. She also runs annual Telomere and Cardiac DNA testing as a biological age assessment to guide ongoing programming.

Dr. Feyrer-Melk uses evidence-based supplements as part of her individualized protocols. These include red yeast rice, magnesium glycinate, ubiquinol, sustained-release niacins, omega-3 fatty acids, and Vitamin D3. She also compounds a special low-dose sustained-release Niacin for patients with individual sensitivities, using supplements either before or alongside prescription medications as clinically appropriate.

Yes. Dr. Feyrer-Melk uses Cleerly Coronary Analysis, an AI-based CT coronary angiography tool that evaluates plaque in the coronary arteries. This technology helps identify the presence and type of plaque that standard imaging may not detect, giving her a more complete picture of each patient's cardiovascular status.

Yes. Dr. Feyrer-Melk welcomes patients from across the country. Initial consultations take place virtually or by phone. All in-person appointments occur at the Scottsdale office, and the practice can suggest hotel accommodations for patients traveling from out of state.